Summary This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next five years. The report explores business and technological trends in the US hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers. The report provides five-year volume and sales forecasts for over 40 hematology and flow cytometry procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers. Strategic Recommendations - New product development opportunities
with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual),
Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual),
Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing. Sales and Market Share Analysis - Sales and market shares of major
instrument and reagent suppliers. Market Segmentation Analysis - Sales and market share estimates for leading suppliers
of hematology and flow cytometry products. - Test and sales forecasts for over 40 procedures
by individual test and market segment: Centralized Testing
- Hospitals
- Commercial/Private Laboratories POC/Decentralized Testing
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- ICUs/CCUs
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers Current and Emerging Products - Analysis of current and emerging hematology and flow cytometry tests.
- Reagent and instrument sales forecasts by market segment.
- Instrument placements and installed base by manufacturer and model.
- Sales and market shares of reagent and instrument suppliers. Technology Review - Assessment of current and emerging
technologies, and their potential market applications. - Comprehensive lists of companies developing
or marketing new technologies and products by test. Competitive Strategies - Extensive strategic profiles of
major suppliers and emerging market entrants. - The companies analyzed in the report include: - Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Iris
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
|